Evidence map›Paper›PMID 39129803›Full record

ArticleJournal of the Society for Cardiovascular Angiography & Interventions

Safety and Effectiveness of Mechanical Thrombectomy From the Fully Enrolled Multicenter, Prospective CLOUT Registry.

David Dexter, Herman Kado, Abdullah Shaikh, Jonathan Schor, Suman Annambhotla, Adam Zybulewski, Joseph Paulisin, Mohannad Bisharat, Nicolas J Mouawad, Matthew C Bunte and 7 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03575364 completednot on this map

ClotTriever Outcomes (CLOUT) Registry

Typeobservational_patient_registrySponsorInari MedicalRan2018 to 2024Enrolled499ConditionsDeep Vein Thrombosis Leg, DVT, Chronic DVT of Lower Extremity, Acute DVT of Lower ExtremityArmsClotTriever
NCT07708376 not yet recruitingnot on this map

Prospective, Multicenter, Registry of the FLOWRUNNER Aspiration System for Safety and Effectiveness in the Removal of Symptomatic Venous Thrombosis (FAST)

Typeobservational_patient_registrySponsorFlowPhysix, Inc.Ran2026 to 2030Enrolled218ConditionsVenous Thrombosis Deep (Limbs), Venous ThrombosisArmsMechanical Thrombectomy - Standard of Care procedure for venous thrombosis
3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prevention of the Postthrombotic Syndrome: Where Do We Stand?Seminars in interventional radiology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Iatrogenic arteriovenous fistula after endovenous mechanical thrombectomy.Journal of vascular surgery cases and innovative techniques · 2024
    Article
  11. Review
  12. Mechanical thrombectomy for inferior vena cava tumor thrombus secondary to renal cell carcinoma.Journal of vascular surgery cases and innovative techniques · 2024
    Article
  13. DETECT-DVT: Detroit Evaluation of Thrombectomy and Evaluation of Intravascular Ultrasound in Deep Vein Thrombosis.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  14. Article
  15. Outcomes From Mechanical Thrombectomy for Deep Vein Thrombosis: Insights From the PINC AI Healthcare Database.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  16. Article
  17. Management of Iliofemoral Venous Stent Thrombosis.Seminars in interventional radiology · 2024
    Review
  18. One-Year Clinical Outcomes Following Mechanical Thrombectomy for Deep Vein Thrombosis: A CLOUT Registry Analysis.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

David DexterSentara Vascular Specialists, Norfolk, Virginia.
Herman KadoAscension Providence Hospital, Farmington Hills, Michigan.
Abdullah ShaikhAllegheny Health Network, Pittsburgh, Pennsylvania.
Jonathan SchorNorthwell Health, Staten Island University Hospital, Staten Island, New York.
Suman AnnambhotlaLongstreet Clinic, Gainesville, Georgia.
Adam ZybulewskiMount Sinai Medical Center of Florida, Miami, Florida.
Joseph PaulisinAscension Michigan Genesys Hospital, Grand Blanc, Michigan.
Mohannad BisharatAshchi Heart and Vascular Center, Jacksonville, Florida.
Nicolas J MouawadMcLaren Bay Heart and Vascular, Bay City, Michigan.
Matthew C BunteSaint Luke's Mid America Heart Institute, Kansas City, Missouri.
Thomas MaldonadoNew York University Langone Health, New York, New York.
Edvard SkripochnikColumbia University Irving Medical Center, New York, New York.
Adam RaskinMercy Heart Institute, Cincinnati, Ohio.
Sagar GandhiPrisma Health, University of South Carolina - School of Medicine, Greenville, South Carolina.
Eugene IchinoseOklahoma Heart Institute, Tulsa, Oklahoma.
Robert BeasleyPalm Vascular Centers, Miami Beach, Florida.
Hamid MojibianYale School of Medicine, New Haven, Connecticut.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We report in-hospital outcomes from the multicenter, prospective, single-arm ClotTriever Outcomes (CLOUT) registry, which enrolled up to 500 patients with proximal lower extremity deep vein thrombosis (DVT) treated with percutaneous mechanical thrombectomy using the ClotTriever System (Inari Medical). Methods: The CLOUT registry enrolled all-comer patients with DVT, irrespective of symptom duration, thrombus age, prior treatment of the current DVT, or bilateral thrombus. The primary effectiveness end point was defined as complete or near complete (≥75%) reduction in Marder score. Thrombus burden was assessed by an independent core laboratory. Mortality and serious adverse events, including device-relatedness, were adjudicated by an independent medical monitor. Here, safety and outcomes are evaluated through discharge. Results: The median age was 61.9 years (IQR, 48.0-70.8), 50.5% were women, 24.9% had a history of DVT, and 23.2% had previously failed treatment of the current DVT. Nearly all procedures (99.4%) were performed in a single session with negligible procedural blood loss (median 40.0 mL; IQR, 20.0-50.0), and most patients (97.8%) required no subsequent intensive care unit monitoring. The primary effectiveness end point was achieved in 91.2% of limbs. Through discharge, 1 device-related serious adverse event (0.2%) occurred. Health status, as assessed by self-reported pain and circumferential measurements of limb edema, were significantly improved at discharge. Conclusions: Thrombectomy with the ClotTriever System is a safe and effective treatment for proximal lower extremity DVT, while also avoiding the need of intensive care. Early patient improvements are demonstrated, and follow-up is ongoing to 2 years.

Indexed as

deep vein thrombosismechanical thrombectomy

Identifiers

PMID39129803
PMCPMC11308834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.